These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 17555374)
1. T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy. Bobisse S; Zanovello P; Rosato A Expert Opin Biol Ther; 2007 Jun; 7(6):893-906. PubMed ID: 17555374 [TBL] [Abstract][Full Text] [Related]
2. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy. Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878 [TBL] [Abstract][Full Text] [Related]
3. Influenza virus-specific TCR-transduced T cells as a model for adoptive immunotherapy. Berdien B; Reinhard H; Meyer S; Spöck S; Kröger N; Atanackovic D; Fehse B Hum Vaccin Immunother; 2013 Jun; 9(6):1205-16. PubMed ID: 23428899 [TBL] [Abstract][Full Text] [Related]
4. Regional Infusion of Chimeric Antigen Receptor T Cells to Overcome Barriers for Solid Tumor Immunotherapy. Hardaway JC; Prince E; Arepally A; Katz SC J Vasc Interv Radiol; 2018 Jul; 29(7):1017-1021.e1. PubMed ID: 29935783 [No Abstract] [Full Text] [Related]
7. A simplified method for the clinical-scale generation of central memory-like CD8+ T cells after transduction with lentiviral vectors encoding antitumor antigen T-cell receptors. Yang S; Dudley ME; Rosenberg SA; Morgan RA J Immunother; 2010; 33(6):648-58. PubMed ID: 20551831 [TBL] [Abstract][Full Text] [Related]
8. Prospects and limitations of T cell receptor gene therapy. Jorritsma A; Schotte R; Coccoris M; de Witte MA; Schumacher TN Curr Gene Ther; 2011 Aug; 11(4):276-87. PubMed ID: 21453279 [TBL] [Abstract][Full Text] [Related]
9. Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer. Perro M; Tsang J; Xue SA; Escors D; Cesco-Gaspere M; Pospori C; Gao L; Hart D; Collins M; Stauss H; Morris EC Gene Ther; 2010 Jun; 17(6):721-32. PubMed ID: 20164855 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3. Lu YC; Parker LL; Lu T; Zheng Z; Toomey MA; White DE; Yao X; Li YF; Robbins PF; Feldman SA; van der Bruggen P; Klebanoff CA; Goff SL; Sherry RM; Kammula US; Yang JC; Rosenberg SA J Clin Oncol; 2017 Oct; 35(29):3322-3329. PubMed ID: 28809608 [TBL] [Abstract][Full Text] [Related]
11. Exploiting T cell receptor genes for cancer immunotherapy. Xue S; Gillmore R; Downs A; Tsallios A; Holler A; Gao L; Wong V; Morris E; Stauss HJ Clin Exp Immunol; 2005 Feb; 139(2):167-72. PubMed ID: 15654813 [TBL] [Abstract][Full Text] [Related]
12. Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma. Sun L; Guo H; Jiang R; Lu L; Liu T; He X Tumour Biol; 2016 Jan; 37(1):799-806. PubMed ID: 26250457 [TBL] [Abstract][Full Text] [Related]
13. Enhanced T cell receptor gene therapy for cancer. Kieback E; Uckert W Expert Opin Biol Ther; 2010 May; 10(5):749-62. PubMed ID: 20201709 [TBL] [Abstract][Full Text] [Related]
14. T-cell receptor gene therapy of established tumors in a murine melanoma model. Abad JD; Wrzensinski C; Overwijk W; De Witte MA; Jorritsma A; Hsu C; Gattinoni L; Cohen CJ; Paulos CM; Palmer DC; Haanen JB; Schumacher TN; Rosenberg SA; Restifo NP; Morgan RA J Immunother; 2008 Jan; 31(1):1-6. PubMed ID: 18157006 [TBL] [Abstract][Full Text] [Related]
15. From CARs to TRUCKs and Beyond: Safely en Route to Adoptive T-cell Therapy for Cancer. Dummy EBioMedicine; 2016 Dec; 14():1-2. PubMed ID: 27986279 [No Abstract] [Full Text] [Related]
16. T-cell receptor gene transfer exclusively to human CD8(+) cells enhances tumor cell killing. Zhou Q; Schneider IC; Edes I; Honegger A; Bach P; Schönfeld K; Schambach A; Wels WS; Kneissl S; Uckert W; Buchholz CJ Blood; 2012 Nov; 120(22):4334-42. PubMed ID: 22898597 [TBL] [Abstract][Full Text] [Related]
17. Life or death of T cells with antigen-specific receptors--using T cells for cancer adoptive immunotherapy/gene therapy. Ren-Heidenreich L; Lum LG Curr Gene Ther; 2001 Sep; 1(3):253-5. PubMed ID: 12109140 [TBL] [Abstract][Full Text] [Related]
18. New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target Malignancies. Schmitt TM; Stromnes IM; Chapuis AG; Greenberg PD Clin Cancer Res; 2015 Dec; 21(23):5191-7. PubMed ID: 26463711 [TBL] [Abstract][Full Text] [Related]
19. Viral Engineering of Chimeric Antigen Receptor Expression on Murine and Human T Lymphocytes. Hammill JA; Afsahi A; Bramson JL; Helsen CW Methods Mol Biol; 2016; 1458():137-57. PubMed ID: 27581020 [TBL] [Abstract][Full Text] [Related]